Epribenz 50mg Injection

About

Epirubicin is an anthracycline topoisomerase II inhibitor, a potent cytotoxic antibiotic widely used in cancer chemotherapy. Its mechanism of action involves several pathways, primarily by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals. These actions lead to DNA damage, inhibition of nucleic acid synthesis, and ultimately, cell death. Epirubicin is effective against a broad spectrum of solid tumors, including breast cancer, gastric cancer, ovarian cancer, and bladder cancer.

It is often administered intravenously as part of multi-drug regimens, playing a crucial role in adjuvant and metastatic settings. A significant consideration with anthracyclines like epirubicin is the dose-dependent risk of cardiotoxicity, necessitating careful monitoring of cardiac function throughout treatment to manage potential long-term cardiac effects. This makes patient selection and monitoring vital for safe and effective use.

Uses

• Adjuvant treatment of early breast cancer.
• Metastatic breast cancer.
• Gastric cancer.
• Ovarian cancer.
• Bladder cancer (intravesical administration).

Directions For Use

Administer intravenously, typically as a short infusion. The exact dose and schedule are determined by your oncologist based on your cancer type, body surface area, and overall health.

Benefits

• Broad-spectrum anticancer activity.
• Effective in various solid tumors.
• Key component in breast cancer regimens.
• Can be used intravesically for bladder cancer.
• Well-established efficacy.
• Part of standard chemotherapy protocols.

Side Effects

• Myelosuppression (low blood counts)
• Nausea
• Vomiting
• Alopecia (hair loss)
• Mucositis/Stomatitis
• Cardiotoxicity (heart damage)
• Red urine (harmless)
• Fatigue
• Anorexia
• Diarrhea
• Injection site reactions
• Amenorrhea

Safety Measures

• Alcohol - Avoid or limit alcohol consumption, as it may exacerbate nausea, vomiting, or liver side effects associated with chemotherapy.
• Pregnancy - Epirubicin is highly teratogenic and contraindicated in pregnancy. Women of childbearing potential must use highly effective contraception during and after treatment.
• Breastfeeding - Breastfeeding is contraindicated during Epirubicin treatment due to the potential for serious adverse reactions in the infant.
• Liver - Dose reduction is necessary in patients with hepatic impairment. Liver function tests must be closely monitored before and during treatment.
• Kidney - Use with caution in patients with severe renal impairment. Dose adjustments may be required based on creatinine clearance.
• Lung - While not a primary lung toxicant, monitor for any new or worsening respiratory symptoms, especially in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.